Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
Clinical trial NCT05490485 · UNKNOWN
Trial details
- NCT number
- NCT05490485
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2024-07-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.